Trial intelligence / Profile preview

Difluprednate for postoperative inflammation

NCT00406341Phase 3Completed

Sponsor
Sirion Therapeutics, Inc.
Start
Apr 2004
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of difluprednate in post-operative inflammation, sponsored by Sirion Therapeutics, Inc.. Started Apr 2004; status: completed.

02

Drugs

difluprednate
03

Conditions

post-operative inflammation

Beyond the preview

Go deeper on NCT00406341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00406341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call